Trends in oral anticoagulation therapy among korean patients with atrial fibrillation: The korean atrial fibrillation investigation

Korean Circulation Journal

Volumn 42, Issue 2, 2012, Pages 113-117

  Shin, Hong Won ^a   Kim, Yoon Nyun ^a   Bae, Han Jun ^a   Lee, Ho Myung ^a   Cho, Hyun Ok ^a   Cho, Yun Kyeong ^a   Park, Hyoung Seob ^a   Yoon, Hyuck Jun ^a   Kim, Hyungseop ^a   Nam, Chang Wook ^a   Hur, Seung Ho ^a   Kim, Kwon Bae ^a   Lee, Young Soo ^b  

^a Dongsan Medical Center   (South Korea)

^b Catholic University of Daegu   (South Korea)

Author keywords

Anticoagulants; Atrial fibrillation; International normalized ratio

Indexed keywords

ANTIVITAMIN K;

ADULT; AGED; ARTICLE; DRUG DOSE; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; INTERNATIONAL NORMALIZED RATIO; KOREA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MULTICENTER STUDY;

EID: 84863271161     PISSN: 17385520     EISSN: 17385555     Source Type: Journal    
DOI: 10.4070/kcj.2012.42.2.113     Document Type: Article

References (17)

1. Singer DE, Albers GW, Dalen JE, et al. Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008;133(6 Suppl):546S-92S.
2. Fuster V, Rydén LE, Cannom DS, et al. 2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 Guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in partnership with the European Society of Cardiology and in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. J Am Coll Cardiol 2011;57:e101-98.
3. Lip GY, Agnelli G, Thach AA, Knight E, Rost D, Tangelder MJ. Oral anti-coagulation in atrial fibrillation: a pan-European patient survey. Eur J Intern Med 2007;18:202-8.
4. Ansell J, Hirsh J, Poller L, Bussey H, Jacobson A, Hylek E. The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004;126(3Suppl):204S-33S.
5. Lee KS, Choi SJ, Park SH, Kim HL, Min H, Park HY. Prevalence of atrial fibrillation in middle-aged people in Korea: the Korean Genome and Epidemiology Study. Korean Circ J 2008;38:601-5.
6. Shen AY, Chen W, Yao JF, Brar SS, Wang X, Go AS. Effect of race/ethnicity on the efficacy of warfarin: potential implications for prevention of stroke in patients with atrial fibrillation. CNS Drugs 2008;22:815-25.
7. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation: a major contributor to stroke in the elderly: the Framingham Study. Arch Intern Med 1987;147:1561-4. (Pubitemid 17138836)
8. Laupacis A, Boysen G, Connolly S, et al. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: analysis of pooled data from five randomized controlled trials. Arch Intern Med 1994;154:1449-57.
9. Kim YH. Rhythm control versus rate control of atrial fibrillation: pharmacologic and non-pharmacologic therapy. Korean Circ J 2003;33:553-8.
10. van Walraven C, Hart RG, Singer DE, et al. Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: an individual patient meta-analysis. JAMA 2002;288:2441-8. (Pubitemid 35340540)
11. Hylek EM, Go AS, Chang Y, et al. Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation. N Engl J Med 2003;349:1019-26. (Pubitemid 37087616)
12. Waldo AL, Becker RC, Tapson VF, Colgan KJ; NABOR Steering Committee. Hospitalized patients with atrial fibrillation and a high risk of stroke are not being provided with adequate anticoagulation. J Am Coll Cardiol 2005;46:1729-36. (Pubitemid 41531631)
13. Stansbury JP, Jia H, Williams LS, Vogel WB, Duncan PW. Ethnic disparities in stroke: epidemiology, acute care, and postacute outcomes. Stroke 2005;36:374-86.
14. van Walraven C, Jennings A, Oake N, Fergusson D, Forster AJ. Effect of study setting on anticoagulation control: a systematic review and metaregression. Chest 2006;129:1155-66.
15. Yasaka M, Minematsu K, Yamaquchi T. Optimal intensity of international normalized ratio in warfarin therapy for secondary prevention of stroke in patients with non-valvular atrial fibrillation. Intern Med 2001;40:1183-8. (Pubitemid 34110494)
16. Miura T, Nishinaka T, Terada T, Yonezawa K. Relationship between aging and dosage of warfarin: the current status of warfarin anticoagulant therapy for Japanese outpatients in a department of cardiovascular medicine. J Cardiol 2009;53:355-60.
17. Atarashi H, Inoue H, Okumura K, Yamashita T, Kumagai N, Origasa H; J-RHYTHM Registry Investigators. Present status of anticoagulation treatment in Japanese patients with atrial fibrillation: a report from the J-RHYTHM Resistry. Circ J 2011;75:1328-33.